Scinai Immunotherapeutics Ratios (2024-2025) | SCNI

Ratios Dec2024 Dec2025
Efficiency
Assets Average (Quarter) 12.54M
Equity Average (Quarter) 9.04M
Invested Capital (Quarter) 9.98M8.10M
Leverage & Solvency
Debt to Equity (Quarter) 0.030.04
Debt Ratio (Quarter) 0.020.03
Equity Ratio (Quarter) 0.740.70
Valuation
Enterprise Value (Quarter) -2.10M-1.81M